Patent AnalyticsExaminers
Rankings

Company or institution

CRISPR THERAPEUTICS AG

170 applicationsfiled 2016 to 2025

Allowance rate
56%
−19 pts vs the USPTO range 48% to 64%
Rejections before allowance
1.8
+0.2 vs the USPTO
Months to first action
25.0 mo
+6.4 vs the USPTO
Needed an RCE
26%
−1 pts vs the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

A61K Medical preparations59 apps
C12N Microorganisms or enzymes53 apps
C07K Peptides48 apps
A61P Therapeutic activity of compounds8 apps
G16B Bioinformatics1 apps
C12Q Measuring or testing processes involving enzymes or nucleic acids1 apps

Art units

163322 apps
163222 apps
169920 apps
OPAP17 apps
163610 apps
163110 apps

Who represents them

Law firms and agents on their applications

Bars show the share of decided applications that were allowed.

Unlock the firms on their applicationsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

ApplicationTitleFiledStatusRejectionsRCEsTo 1st action
19627750GENETICALLY MODIFIED CELLS EXPRESSING GLP-1 RECEPTOR AGONIST2026-09-24Pending00n/a
19621666MODULATING EXPRESSION OF AGT (ANGIOTENSINOGEN) GENE2026-09-04Pending00n/a
19618867RT EDITING COMPOSITIONS AND METHODS2026-08-26Pending00n/a
15419122Method and apparatus for adaptive signal processing2012-01-10Allowed1012.0 mo
15843894Composition and method for controlled release2015-02-11Abandoned4123.0 mo
15918122Distributed ledger transaction verification2018-03-12Allowed3020.0 mo
15992532Thermal management of battery assemblies2021-04-13Pending2117.0 mo
15852750Machine learning model for anomaly detection2012-05-14Allowed1014.0 mo
15222409Wireless power transfer coil arrangement2015-06-15Abandoned4125.0 mo
15978420Catalyst for selective hydrogenation2018-07-16Allowed3022.0 mo
Unlock all 170 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in